SEARCH

SEARCH BY CITATION

Keywords:

  • autophagy;
  • cellular reprogramming;
  • iPSC;
  • stem cells;
  • stemness

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

Stem cells have the ability to self-renew and differentiate into various cell types. Both cell-intrinsic and extrinsic factors may contribute to aging-related decline in stem cell function and loss of stemness. The maintenance of cellular homeostasis requires timely removal of toxic proteins and damaged organelles that accumulate with age or in pathological conditions. Autophagy is one of the main strategies to eliminate unwanted cytoplasmic materials thereby ultimately preventing cellular damage. Here, we shall discuss the accumulating evidence suggesting that autophagy plays a critical role in the homeostatic control of stem cell functions during aging, tissue regeneration, and cellular reprogramming.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

Macroautophagy (hereafter referred to as autophagy) is a basic mechanism of degrading unnecessary or dysfunctional cell components. It is characterized by the engulfment of the targeted components in double-membrane bound autophagosomes followed by their fusion with lysosomes. Two ubiquitin-like conjugation systems are involved in the formation of autophagosomes: (1) ATG12 is covalently linked to ATG5 through ATG7, an E1-like enzyme, and ATG10, an E2-like enzyme; (2) microtubule-associated protein light chain-3 (LC3) is covalently linked to phosphatidylethanolamine (PE) through ATG7 and ATG3, an E2-like enzyme (Rubinsztein et al, 2011). Once autophagosomes are formed, their outer membranes fuse with lysosomes, with consequent disintegration of the inner autophagosomal membranes and degradation of the contents of autophagosomes by lysosomal enzymes. The produced catabolites include amino acids (AA), free fatty acids (FFA) and others, which are rapidly made available in the cytoplasm for recycling (Wirawan et al, 2012).

In somatic cells, the quality control of long-lived proteins and organelles is ensured by autophagy. Indeed, the autophagic process targets and degrades misfolded proteins or functionally impaired organelles thus preventing toxic effects due to their accumulation (Rubinsztein et al, 2011). The autophagic pathway can be activated by different stimuli including starvation, endoplasmic reticulum stress, DNA damage, and reactive oxygen species (ROS). The level of autophagic activity is tightly regulated through a number of signalling pathways (Egan et al, 2011; Rubinsztein et al, 2011).

While our knowledge of autophagy in somatic cell physiology is extensive, the role of autophagy in stem cells is much less understood. Recent studies have implicated autophagy in the homeostatic control and maintenance of the self-renewal capacity of stem cells. Additionally, autophagy may also participate in stem cell differentiation and somatic reprogramming (Vessoni et al, 2012). Under certain circumstances, autophagy can also trigger a cell death program termed autophagic cell death (Maiuri et al, 2007). In this Perspective, we mainly focus on the protective role of autophagy in various stem cell types.

Autophagy in various stem cell types

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

A recent study has shown that the level of constitutive autophagy in human mesenchymal stem cells (hMSC) is high. Once hMSCs are differentiated into osteoblasts, however, basal autophagy becomes undetectable, suggesting that it is down regulated during hMSC differentiation (Oliver et al, 2012). Lee et al reported that autophagy induced by hypoxia promotes the maintenance and self-renewal of MSC (Lee et al, 2012; Fig 1A). Moreover, it was recently reported that activation of autophagy antagonized, while inhibition of autophagy promoted MSC apoptosis during hypoxia/serum deprivation (Zhang et al, 2012c; Fig 1A).

thumbnail image

Figure 1. Autophagy in stem cell activity and function.

  • A.
    Autophagy is required for the maintenance of MSCs and inhibits their death.
  • B.
    Autophagy remains at high levels in HSCs, DSCs and Epi-SCs, and promotes their maintenance; after induced differentiation, autophagic activity is down regulated.
  • C.
    Autophagy in NSCs, CSCs and ESCs is up regulated during their differentiation.
  • D.
    Autophagy is required for the maintenance and the tumourigenic potential of BCSCs, enhances the survival of PCSCs, and plays an important role in GSC migration.
  • E.
    Autophagy increases the reprogramming efficiency, and promotes the generation of iPSC.
  • F.
    Autophagosome clearance is inhibited in PD-iPSC-derived dopaminergic neurons (DAn).
  • G.
    Rapamycin, an autophagy inducer, can effectively facilitate the degradation of progerin and thus prevent progeria-associated ageing phenotypes in Hutchinson-Gilford progeria syndrome (HGPS) fibroblasts.

Download figure to PowerPoint

Autophagic activity has also been shown to be constitutively high in hematopoietic stem cells (HSC), dermal stem cells (DSC), and epidermal stem cells (Epi-S; Salemi et al, 2012). After induced differentiation, autophagic activity in immature keratinocytes, fibroblasts and neutrophils is down regulated to a basal level similar to that observed in most cell types (Salemi et al, 2012; Fig 1B). Other lines of evidence have shown that autophagy is required for the maintenance of HSCs (Liu et al, 2010; Mortensen et al, 2010, 2011a, b; Fig 1B). The specific deficiency of two essential autophagy genes FIP200 or Atg7, in mouse HSCs leads to their dysfunction and loss at the perinatal stage, and dysregulated myeloproliferation, suggesting a defect in self-renewal (Liu et al, 2010; Mortensen et al, 2011a).

At variance with MSCs, HSCs, DSCs and Epi-S', autophagy is up regulated during differentiation of neural and cardiac stem cells (NSC and CSC; Vazquez et al, 2012; Zhang et al, 2012a, b; Fig 1C). The expression of several main autophagy genes is increased in mouse embryonic olfactory bulb (OB) during the early stages of neuronal differentiation. Neurogenesis is markedly decreased when autophagy is blocked by chemicals (Vazquez et al, 2012). Neuronal differentiation is also impaired in Ambra1-null mice, Ambra1 haplodeficient cells and Atg5-null OB cells, further supporting the notion that autophagy plays a role in NSC differentiation (Vazquez et al, 2012). Similarly, inhibition of autophagy significantly inhibits CSC differentiation, while the same process is promoted by activation of autophagy (Zhang et al, 2012a, b).

Autophagy has also been reported to be rapidly up regulated during early differentiation of mouse embryonic stem cells (mESC) and human embryonic stem cells (hESC; Tra et al, 2011; Fig 1C). The deficiency of autophagy genes in mESCs during embryogenesis has long been studied (Mizushima et al, 2001). Null mutations of beclin1 in mESCs lead to early embryonic lethality (Yue et al, 2003), whereas impairment of autophagy caused by Ambra1 deficiency undermines the development of the nervous system (Maria Fimia et al, 2007). Moreover, deletion of Atg5 or Beclin 1 in mESC leads to compromised engulfment and clearance of apoptotic cells and the formation of defective embryoid bodies, further suggesting a critical role for autophagy in early embryonic development (Qu et al, 2007).

In addition to its functions in ‘normal’ stem cells, recent studies revealed that autophagy plays roles in cancer stem cells (also known as tumour initiating cells). Primary breast cancer stem cells (BCSC) have been shown to have a very high autophagic activity (Gong et al, 2012) and indeed knockdown of Beclin 1 and Atg7 in several BCSC lines leads to a significant impairment of self-renewal and a decline of tumourigenic potential (Gong et al, 2012) (Fig 1D). Another report suggested that autophagy could promote the survival of pancreatic cancer stem cells (PCSC; Singh et al, 2012; Fig 1D). In addition, autophagy also plays a significant role in glioblastoma stem cell (GSC) migration and invasion by modulating ATP metabolism and remodelling subcellular structures, such as regulating mitochondrial fusion (Galavotti et al, 2012; Fig 1D).

Autophagy in somatic reprogramming

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

Autophagy has also been shown to participate in the regulation of the somatic reprogramming process. Indeed, pharmacological induction of autophagy increases the reprogramming efficiency of mouse embryonic fibroblasts (MEF) to induced pluripotent stem cells (iPSC; Chen et al, 2011; Fig 1E). These findings suggest the intriguing possibility that autophagy could serve as a positive regulator of induced pluripotency. The mechanisms through which autophagy might facilitate somatic reprogramming are not well understood. Autophagy might promote the induction of pluripotency by counteracting cellular senescence and apoptosis, both thought to be barriers to reprogramming (Menendez et al, 2011). Furthermore, ESCs have fewer mitochondria than their differentiated counterparts, which is consistent with the idea that mitochondrial oxidative phosphorylation leads to more ROS that may in turn impair long-term self-renewal of ESC (Armstrong et al, 2010). The autophagic degradation of mitochondria may ultimately improve the efficiency of reprogramming (Vazquez-Martin et al, 2012; Vessoni et al, 2012).

. . .autophagy may serve as a critical mechanism for the regulation of self-renewal and differentiation.

Autophagy in iPSC-based disease models

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

Recent studies have established that autophagy could play significant roles in the pathogenesis of age-related diseases, especially neurodegenerative disorders (Hara et al, 2006; Harris & Rubinsztein, 2012; Shintani & Klionsky, 2004; Winslow & Rubinsztein, 2011). An accumulation of autophagic vacuoles was detected during the differentiation of iPSC generated from idiopathic Parkinson's disease (PD) and familial PD [associated with a mutation in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene] patients, to dopaminergic neurons (Sánchez-Danés et al, 2012). Moreover, induction of autophagy and/or inhibition of lysosomal proteolysis enhanced dopaminergic neuron phenotypic alterations, indicating that the defective maturation of autophagosomes into autophagolysosomes partially contributes to the LRRK2-associated PD phenotypes (Sánchez-Danés et al, 2012; Fig 1F). On the other hand, the stimulation of the autophagic pathway has been shown to slow down both physiological and premature aging processes. Induction of autophagy by rapamycin in Hutchinson–Gilford progeria syndrome (HGPS) fibroblasts can facilitate the elimination of progerin, the causative agent of accelerated cellular senescence, and thus the normalization of most progeria-associated cellular and molecular phenotypes (Cao et al, 2011; Fig 1G). Recently, three groups, including our own, have successfully generated iPSCs from progeria patients (Ho et al, 2011; Liu et al, 2011a, b; Zhang et al, 2011). Differentiation of progeria iPSCs into mesodermal tissues recapitulated the premature aging features after extended in vitro culture or under stress conditions. These defective iPSC derivatives will be valuable tools to study cell-type specific roles of autophagy in the development of cellular senescence and will also provide a platform to screen for the best autophagy regulators for potential pharmacological intervention of these accelerated aging disorders.

Perspectives

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

The implication of autophagy in the maintenance of stemness adds a new layer of control on stem cell activity. Firstly, autophagy may serve as a critical mechanism for the regulation of self-renewal and differentiation. Indeed, stem cells require especially efficient protein turnover to eliminate unwanted proteins, which may otherwise accumulate and impair identity and function. Both autophagy and the ubiquitin-proteasome system (UPS) are important for protein quality control and the maintenance of cellular homeostasis, and they cooperate to regulate cellular aging (Jana, 2012; Rubinsztein, 2006). Dysfunction or decrease of the stem cell pools is typical of physiological and pathological aging; it would be therefore interesting to determine how these two protein degradation pathways are coordinated in the regulation of stem cell homeostasis, and how the dysregulation of autophagy in stem cells is linked to aging and degenerative diseases. Additionally, the involvement of autophagy in somatic reprogramming suggests a new methodological basis for developing strategies to efficiently generate iPSCs. Finally, increased autophagy may enable cells to overcome the cellular senescence barrier by remodelling the cell cycle machinery or by promoting the turnover of the ‘senescent’ subcellular architecture.

. . .autophagy may enable cells to overcome the cellular senescence barrier by remodelling the cell cycle machinery or by promoting the turnover of the ‘senescent’ subcellular architecture.

In summary, the study of the interplay between autophagy and cell stemness will not only increase our understanding of the mechanisms and pathways through which autophagy contributes to stem cell maintenance and differentiation, but also enhance our knowledge of the roles of autophagy in human development, aging, and various degenerative diseases (Sánchez-Danés et al, 2012). Stem cell rejuvenation and function and large-scale production of high quality transplantable materials through active manipulation of autophagic pathways using small molecules and/or targeted genome-editing technology may be more than a dream.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References

GHL was supported by the Thousand Young Talents program of China, the National Laboratory of Biomacromolecules, the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), and NSFC (81271266, 31222039, 31201111). ML is supported by a CIRM fellowship. JCIB was supported by TERCEL-ISCIII-MINECO, CIBER, Fundacion Cellex, G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and The Ellison Medical Foundation.

The authors declare that they have no conflict of interest.

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Autophagy in various stem cell types
  5. Autophagy in somatic reprogramming
  6. Autophagy in iPSC-based disease models
  7. Perspectives
  8. Acknowledgements
  9. References
  • Armstrong L, Tilgner K, Saretzki G, Atkinson SP, Stojkovic M, Moreno R, Przyborski S, Lako M (2010) Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 28: 661- 673
  • Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS (2011) Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 3: 89ra58
  • Chen T, Shen L, Yu J, Wan H, Guo A, Chen J, Long Y, Zhao J, Pei G (2011) Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 10: 908- 911
  • Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, et al (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456- 461
  • Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, et al (2012) The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene DOI: 10.1038/onc.2012.111 [Epub ahead of print].
  • Gong C, Bauvy C, Tonelli G, Yue W, Delomenie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V, Tharinger H, et al (2012) Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene DOI: 10.1038/onc.2012.252 [Epub ahead of print].
  • Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885- 889
  • Harris H, Rubinsztein DC (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8: 108- 117
  • Ho JC, Zhou T, Lai WH, Huang Y, Chan YC, Li X, Wong NL, Li Y, Au KW, Guo D, et al (2011) Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging 3: 380- 390
  • Jana NR (2012) Protein homeostasis and aging: role of ubiquitin protein ligases. Neurochem Int 60: 443- 447
  • Lee Y, Jung J, Cho KJ, Lee SK, Park JW, Oh IH, Kim GJ (2012) Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem 114: 79- 88
  • Liu F, Lee JY, Wei H, Tanabe O, Engel JD, Morrison SJ, Guan J-L (2010) FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 116: 4806- 4814
  • Liu G-H, Barkho BZ, Ruiz S, Diep D, Qu J, Yang S-L, Panopoulos AD, Suzuki K, Kurian L, Walsh C, et al (2011a) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472: 221- 225
  • Liu G-H, Suzuki K, Qu J, Sancho-Martinez I, Yi F, Li M, Kumar S, Nivet E, Kim J, Soligalla Rupa D, et al (2011b) Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8: 688- 694
  • Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Rev Mol Cell Biol 8: 741- 752
  • Maria Fimia G, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, Corazzari M, Fuoco C, Ucar A, Schwartz P, et al (2007) Ambra1 regulates autophagy and development of the nervous system. Nature v447: 1121- 1125
  • Menendez JA, Vellon L, Oliveras-Ferraros C, Cufi S, Vazquez-Martin A (2011) mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 10: 3658- 3677
  • Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T (2001) Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 152: 657- 668
  • Mortensen M, Ferguson DJP, Edelmann M, Kessler B, Morten KJ, Komatsu M, Simon AK (2010) Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci 107: 832- 837
  • Mortensen M, Soilleux EJ, Djordjevic G, Tripp R, Lutteropp M, Sadighi-Akha E, Stranks AJ, Glanville J, Knight S, Jacobsen W, et al (2011a) The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 208: 455- 467
  • Mortensen M, Watson AS, Simon AK (2011b) Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy 7: 1069- 1070
  • Oliver L, Hue E, Priault M, Vallette FM (2012) Basal autophagy decreased during the differentiation of human adult mesenchymal stem cells. Stem Cells Dev 21: 2779- 2788
  • Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C, Levine B (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128: 931- 946
  • Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443: 780- 786
  • Rubinsztein David C, Mariño G, Kroemer G (2011) Autophagy and aging. Cell 146: 682- 695
  • Sánchez-Danés A, Richaud-Patin Y, Carballo-Carbajal I, Jiménez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, et al (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med 4: 380- 395
  • Salemi S, Yousefi S, Constantinescu MA, Fey MF, Simon H-U (2012) Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell Res 22: 432- 435
  • Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306: 990- 995
  • Singh BN, Kumar D, Shankar S, Srivastava RK (2012) Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol 84: 1154- 1163
  • Tra T, Gong L, Kao LP, Li XL, Grandela C, Devenish RJ, Wolvetang E, Prescott M (2011) Autophagy in human embryonic stem cells. PloS One 6: e27485
  • Vazquez-Martin A, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Vellon L, Menendez JA (2012) Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness. Aging 4: 393- 3401
  • Vazquez P, Arroba AI, Cecconi F, de la Rosa EJ, Boya P, de Pablo F (2012) Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy 8: 187- 199
  • Vessoni AT, Muotri AR, Okamoto OK (2012) Autophagy in stem cell maintenance and differentiation. Stem Cells Dev 21: 513- 520
  • Winslow AR, Rubinsztein DC (2011) The Parkinson disease protein alpha-synuclein inhibits autophagy. Autophagy 7: 429- 431
  • Wirawan E, Berghe TV, Lippens S, Agostinis P, Vandenabeele P (2012) Autophagy: for better or for worse. Cell Res 22: 43- 61
  • Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci 100: 15077- 15082
  • Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y, Tse H-F, et al (2011) A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8: 31- 45
  • Zhang J, Liu J, Huang Y, Chang JY, Liu L, McKeehan WL, Martin JF, Wang F (2012a) FRS2alpha-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res 110: e29- e39
  • Zhang J, Liu J, Liu L, McKeehan WL, Wang F (2012b) The fibroblast growth factor signaling axis controls cardiac stem cell differentiation through regulating autophagy. Autophagy 8: 690- 691
  • Zhang Q, Yang YJ, Wang H, Dong QT, Wang TJ, Qian HY, Xu H (2012c) Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev 21: 1321- 1332